Ulcerative Colitis Treatment | Lialda® (mesalamine)

Meet Emily.

Emily teaches, Emily inspires, Emily doesn’t let
ulcerative colitis symptoms keep her
from what’s important.

When there are less UC symptoms, there’s more time to be you.

Lialda^® can help control the symptoms of a UC flare-up and help begin healing the lining of the colon by reducing inflammation. In fact, Lialda is the only once-daily UC medication proven to help achieve remission.

Learn more about how Lialda can help you get to UC remission

Are your ulcerative colitis symptoms under control?

Take our UC Flare Assessment.

Custom Doctor Discussion Guide

Create your own and get more from your next conversation with your doctor.

Connect 2 More

Lialda is approved for the induction of remission in patients with active, mild to moderate ulcerative colitis. The safety and effectiveness of Lialda have been established in 2 eight-week clinical trials.

Important Safety Information

You should not take Lialda if you are allergic to salicylates (including mesalamine or aspirin) or to any of the ingredients of Lialda. Tell your doctor if you have a stomach blockage or are allergic to sulfasalazine. Mesalamine has been associated with a syndrome that may be difficult to distinguish from an ulcerative colitis flare-up. If you experience cramping, abdominal pain, bloody diarrhea, fever, headache or rash, talk to your doctor immediately. Some patients taking mesalamine have reported heart-related hypersensitivity reactions, such as inflammation of the heart muscle and inflammation of the lining of the heart. Tell your doctor if you have problems with your liver or kidneys.

In worldwide clinical trials, Lialda was generally well tolerated. The most common adverse events were headache and flatulence. As with other medications, some serious side effects may occur. Less than 1% of patients experienced inflammation of the pancreas, which led to discontinuation of therapy with Lialda.

Please see Lialda Full Prescribing Information

Site Map | Contact Us | Privacy Policy | Unsubscribe | Shire US Inc.

©2009 LIA-00772 09/09
Lialda^® is a registered trademark of Shire LLC. MMX^® is a registered trademark owned by Cosmo Technologies Ltd, Ireland, a wholly-owned subsidiary of Cosmo Pharmaceuticals SpA.
© 2009 Shire US Inc., Wayne, PA 19087 (800) 828-2088. All rights reserved.

This site is strictly intended for US residents and is governed solely by US laws and governmental regulations. Please see our online privacy policy for more information.

While Shire US Inc. makes reasonable efforts to include accurate, up-to-date information on the site, Shire US Inc. makes no warranties or representations as to its accuracy. Shire US Inc. assumes no liability for any errors or omissions in the content of the site.